PMID- 19435668 OWN - NLM STAT- MEDLINE DCOM- 20091008 LR - 20131121 IS - 1464-3391 (Electronic) IS - 0968-0896 (Linking) VI - 17 IP - 11 DP - 2009 Jun 1 TI - Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2. PG - 3789-94 LID - 10.1016/j.bmc.2009.04.046 [doi] AB - Endogenous mu-opioid receptor (MOR) selective peptides, endomorphin-1 (EM-1) and endomorphin-2 (EM-2), unlike so called 'typical opioids', are characterized by the presence of Pro(2) residue, which is a spacer connecting aromatic pharmacophoric residues. In order to investigate structural requirements for position 2, we synthesized endomorphin analogs incorporating, instead of Pro, unnatural amino acids with six-membered heterocyclic rings, such as piperidine 2-, 3- or 4-carboxylic acids (Pip, Nip and Inp, respectively). (R)-Nip residue turned out to be favourable for improving MOR affinity. Introduction of 2',6'-dimethyltyrosine (Dmt) instead of Tyr(1) led to obtaining [Dmt(1), (R)-Nip(2)]EM-2 which showed exceptional MOR affinity and high stability against enzymatic degradation in rat brain homogenate. In in vivo hot-plate test in mice, this analog given intracerebroventicularly (i.c.v.), produced profound supraspinal analgesia, being much more potent than EM-2. The antinociceptive effect of this analog lasted about 170 min and was almost completely reversed by beta-funaltrexamine (beta-FNA), a selective MOR antagonist. FAU - Perlikowska, Renata AU - Perlikowska R AD - Laboratory of Biomolecular Chemistry, Institute of Biomedicinal Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland. FAU - Gach, Katarzyna AU - Gach K FAU - Fichna, Jakub AU - Fichna J FAU - Toth, Geza AU - Toth G FAU - Walkowiak, Bogdan AU - Walkowiak B FAU - do-Rego, Jean-Claude AU - do-Rego JC FAU - Janecka, Anna AU - Janecka A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090503 PL - England TA - Bioorg Med Chem JT - Bioorganic & medicinal chemistry JID - 9413298 RN - 0 (Analgesics) RN - 0 (Analgesics, Opioid) RN - 0 (Oligopeptides) RN - 0 (Peptides) RN - 0 (endomorphin 1) RN - 9DLQ4CIU6V (Proline) SB - IM MH - Amino Acid Sequence MH - Analgesics/chemistry/pharmacology MH - Analgesics, Opioid/*chemistry/pharmacology MH - Animals MH - Brain/drug effects MH - Chromatography, High Pressure Liquid MH - Dose-Response Relationship, Drug MH - Male MH - Mice MH - Molecular Sequence Data MH - Molecular Structure MH - Oligopeptides/*chemistry/pharmacology MH - Peptides/chemical synthesis/chemistry MH - Proline/*chemistry/metabolism MH - Rats EDAT- 2009/05/14 09:00 MHDA- 2009/10/09 06:00 CRDT- 2009/05/14 09:00 PHST- 2009/01/23 00:00 [received] PHST- 2009/04/20 00:00 [revised] PHST- 2009/04/22 00:00 [accepted] PHST- 2009/05/14 09:00 [entrez] PHST- 2009/05/14 09:00 [pubmed] PHST- 2009/10/09 06:00 [medline] AID - S0968-0896(09)00406-4 [pii] AID - 10.1016/j.bmc.2009.04.046 [doi] PST - ppublish SO - Bioorg Med Chem. 2009 Jun 1;17(11):3789-94. doi: 10.1016/j.bmc.2009.04.046. Epub 2009 May 3.